Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03681873 · ClinicalTrials.gov registry record · NA

Validation of Low Dose CT for Diagnosis of Lung Nodules

A NA study of Cancer and Metastasis to Lung, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT03681873 is a NA study of Cancer and Metastasis to Lung that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 78 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03681873, a NA study of Cancer and Metastasis to Lung, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The investigators have developed an extremely low dose computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of two chest radiographs. The investigators plan to test this exam in patients with known or suspected cancer undergoing clinically indicated chest CT.

Interventions

  • DIAGNOSTIC_TEST Extremely Low Dose CT

Study Locations (1)

Ohio

  • Cincinnati Children's Hospital Medical Center Burnet Campus - Cincinnati

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2018-11-30
Est. Completion 2021-09-07
Phase NA

What the Registry Record Tells You About NCT03681873

The ClinicalTrials.gov registry entry for NCT03681873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Extremely Low Dose CT is the first listed.

NCT03681873 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03681873 about?

NCT03681873 is a clinical study titled "Validation of Low Dose CT for Diagnosis of Lung Nodules". The investigators have developed an extremely low dose computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of two chest radiographs. The investigators plan to test this exam in patients with known or suspected cancer undergoing clinically indicated chest ...

What is the current status of trial NCT03681873?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2018-11-30. Estimated completion is 2021-09-07.

What conditions does trial NCT03681873 study?

This clinical trial studies the following conditions: Cancer, Metastasis to Lung.

What interventions are being tested in trial NCT03681873?

The interventions under investigation include: Extremely Low Dose CT (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03681873?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03681873 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.